Pathophysiology and treatment of nonalcoholic fatty liver disease (NAFLD): Effects of bariatric surgery
Not Applicable
Completed
- Conditions
- ObesityNon-alcoholic fatty liver diseaseBariatric SurgeryDiet and Nutrition - ObesityOral and Gastrointestinal - Other diseases of the mouth, teeth, oesophagus, digestive system including liver and colonSurgery - Other surgery
- Registration Number
- ACTRN12615000874516
- Lead Sponsor
- Centre for Obesity Research and Education, Monash University
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- All
- Target Recruitment
- 190
Inclusion Criteria
Patients >17 years undergoing bariatric surgery and any of:
- AST or ALT > 0.5 upper limit normal
- GGT > upper limit normal
- Abnormal transient elastography
- Abnormal ultrasound suggesting NAFLD
Exclusion Criteria
Other cause of liver disease
Past or current excessive ETOH
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Changes in liver histology with surgically induced weight loss (comparison of baseline liver biopsy with follow-up liver biopsy)[1 year]
- Secondary Outcome Measures
Name Time Method Changes in immune cell infiltrate and expression of TNFSF14/LIGHT (immune cell related marker) in NASH with weight loss (as investigated via immunohistochemistry of liver). [1 year]